These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pain is associated with reduced quality of life and functional status in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Strand EB, Mengshoel AM, Sandvik L, Helland IB, Abraham S, Nes LS. Scand J Pain; 2019 Jan 28; 19(1):61-72. PubMed ID: 30325738 [Abstract] [Full Text] [Related]
5. Comorbidity in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: A Nationwide Population-Based Cohort Study. Castro-Marrero J, Faro M, Aliste L, Sáez-Francàs N, Calvo N, Martínez-Martínez A, de Sevilla TF, Alegre J. Psychosomatics; 2017 Jan 28; 58(5):533-543. PubMed ID: 28596045 [Abstract] [Full Text] [Related]
6. How common are depression and anxiety in adolescents with chronic fatigue syndrome (CFS) and how should we screen for these mental health co-morbidities? A clinical cohort study. Loades ME, Read R, Smith L, Higson-Sweeney NT, Laffan A, Stallard P, Kessler D, Crawley E. Eur Child Adolesc Psychiatry; 2021 Nov 28; 30(11):1733-1743. PubMed ID: 32964335 [Abstract] [Full Text] [Related]
7. Prevalence and treatment of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and co-morbid severe health anxiety. Daniels J, Parker H, Salkovskis PM. Int J Clin Health Psychol; 2020 Nov 28; 20(1):10-19. PubMed ID: 32021614 [Abstract] [Full Text] [Related]
8. Comorbidities treated in primary care in children with chronic fatigue syndrome / myalgic encephalomyelitis: A nationwide registry linkage study from Norway. Bakken IJ, Tveito K, Aaberg KM, Ghaderi S, Gunnes N, Trogstad L, Magnus P, Stoltenberg C, Håberg SE. BMC Fam Pract; 2016 Sep 02; 17(1):128. PubMed ID: 27590471 [Abstract] [Full Text] [Related]
9. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression. Maes M, Twisk FN, Ringel K. Psychother Psychosom; 2012 Sep 02; 81(5):286-95. PubMed ID: 22832503 [Abstract] [Full Text] [Related]
10. Poor sleep quality is associated with greater circulating pro-inflammatory cytokines and severity and frequency of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) symptoms in women. Milrad SF, Hall DL, Jutagir DR, Lattie EG, Ironson GH, Wohlgemuth W, Nunez MV, Garcia L, Czaja SJ, Perdomo DM, Fletcher MA, Klimas N, Antoni MH. J Neuroimmunol; 2017 Feb 15; 303():43-50. PubMed ID: 28038892 [Abstract] [Full Text] [Related]
11. Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians. Bested AC, Marshall LM. Rev Environ Health; 2015 Feb 15; 30(4):223-49. PubMed ID: 26613325 [Abstract] [Full Text] [Related]
12. Defining the prevalence and symptom burden of those with self-reported severe chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a two-phase community pilot study in the North East of England. Strassheim VJ, Sunnquist M, Jason LA, Newton JL. BMJ Open; 2018 Sep 19; 8(9):e020775. PubMed ID: 30232103 [Abstract] [Full Text] [Related]
14. Treatment for paediatric chronic fatigue syndrome or myalgic encephalomyelitis (CFS/ME) and comorbid depression: a systematic review. Loades ME, Sheils EA, Crawley E. BMJ Open; 2016 Oct 11; 6(10):e012271. PubMed ID: 27729349 [Abstract] [Full Text] [Related]
15. How do women with chronic fatigue syndrome/myalgic encephalomyelitis rate quality and coordination of healthcare services? A cross-sectional study. Hansen AH, Lian OS. BMJ Open; 2016 Apr 04; 6(4):e010277. PubMed ID: 27044578 [Abstract] [Full Text] [Related]
16. Exploratory study into the relationship between the symptoms of chronic fatigue syndrome (CFS)/myalgic encephalomyelitis (ME) and fibromyalgia (FM) using a quasiexperimental design. Mckay PG, Walker H, Martin CR, Fleming M. BMJ Open; 2021 Feb 01; 11(2):e041947. PubMed ID: 33526500 [Abstract] [Full Text] [Related]
17. In myalgic encephalomyelitis/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation. Maes M, Ringel K, Kubera M, Anderson G, Morris G, Galecki P, Geffard M. J Affect Disord; 2013 Sep 05; 150(2):223-30. PubMed ID: 23664637 [Abstract] [Full Text] [Related]
18. Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study. Lidbury BA, Kita B, Lewis DP, Hayward S, Ludlow H, Hedger MP, de Kretser DM. J Transl Med; 2017 Mar 16; 15(1):60. PubMed ID: 28302133 [Abstract] [Full Text] [Related]
19. Experiences of daily activity in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) and their implications for rehabilitation programmes. Pemberton S, Cox DL. Disabil Rehabil; 2014 Mar 16; 36(21):1790-7. PubMed ID: 24369769 [Abstract] [Full Text] [Related]
20. Lower whole blood glutathione peroxidase (GPX) activity in depression, but not in myalgic encephalomyelitis / chronic fatigue syndrome: another pathway that may be associated with coronary artery disease and neuroprogression in depression. Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E. Neuro Endocrinol Lett; 2011 Mar 16; 32(2):133-40. PubMed ID: 21552194 [Abstract] [Full Text] [Related] Page: [Next] [New Search]